GBP2 serves as a novel prognostic biomarker and potential immune microenvironment indicator in renal cell carcinoma

Since the application of immune checkpoint therapy (ICT) has gradually become a new strategy for clear cell renal cell carcinoma (ccRCC) treatment, biomarkers that predict the individual response to ICT is needed. This study aimed to identify a new clinical indicator for postoperative surveillance o...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Molecular carcinogenesis 2022-12, Vol.61 (12), p.1082-1098
Hauptverfasser:	Tian, Yijun, Wang, Hongru, Guan, Wenbin, Tu, Xiaohua, Zhang, Xiangmin, Sun, Ye, Qian, Cheng, Song, Xu, Peng, Bo, Cui, Xingang
Format:	Artikel
Sprache:	eng
Schlagworte:	Apoptosis biomarker Biomarkers Biomarkers, Tumor - metabolism Carcinoma, Renal Cell - pathology Cholecystokinin clear cell renal cell carcinoma Clear cell-type renal cell carcinoma GBP2 GTP-Binding Proteins - metabolism Humans Immune checkpoint immune checkpoint therapy Immunohistochemistry Kidney cancer Kidney Neoplasms - pathology Lymphocytes Malignancy Metastases Patients Prognosis Tumor Microenvironment
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!